Transcriptome signatures preceding the induction of anti-stalk antibodies elicited after universal influenza vaccination | npj Vaccines
Subset of Kappa and Lambda Germline Sequences Result in Light Chains with a Higher Molecular Mass Phenotype | Journal of Proteome Research
IJMS | Free Full-Text | Free Light Chains κ and λ as New Biomarkers of Selected Diseases
Transcriptome signatures preceding the induction of anti-stalk antibodies elicited after universal influenza vaccination | npj Vaccines
Population matched (pm) germline allelic variants of immunoglobulin (IG) loci: Relevance in infectious diseases and vaccination studies in human populations | Genes & Immunity
Paired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses - ScienceDirect
Immunoglobulin germline gene variation and its impact on human disease | Genes & Immunity
A novel STING agonist-adjuvanted pan-sarbecovirus vaccine elicits potent and durable neutralizing antibody and T cell responses in mice, rabbits and NHPs | Cell Research
Microorganisms | Free Full-Text | SARS-CoV-2 versus Influenza A Virus: Characteristics and Co-Treatments
Signs of immunosenescence correlate with poor outcome of mRNA COVID-19 vaccination in older adults | Nature Aging
COVAC1 phase 2a expanded safety and immunogenicity study of a self-amplifying RNA vaccine against SARS-CoV-2 - eClinicalMedicine
Vaccines | Free Full-Text | Influenza–Host Interplay and Strategies for Universal Vaccine Development
Vaccines | Free Full-Text | Immune Control of Avian Influenza Virus Infection and Its Vaccine Development
Sequence signatures of two public antibody clonotypes that bind SARS-CoV-2 receptor binding domain | Nature Communications
A recombinant protein containing influenza viral conserved epitopes and superantigen induces broad-spectrum protection | eLife
Frontiers | Fast-track development of vaccines for SARS-CoV-2: The shots that saved the world
Vaccines | Free Full-Text | Variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Vaccine Effectiveness
Inactivated vaccine-elicited potent antibodies can broadly neutralize SARS-CoV-2 circulating variants | Nature Communications
Vaccines | Free Full-Text | Emerging SARS-CoV-2 Variants: A Review of Its Mutations, Its Implications and Vaccine Efficacy
Enhanced virulence and waning vaccine-elicited antibodies account for breakthrough infections caused by SARS-CoV-2 delta and beyond - ScienceDirect
Subset of Kappa and Lambda Germline Sequences Result in Light Chains with a Higher Molecular Mass Phenotype | Journal of Proteome Research
Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose booster - eBioMedicine
Paired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses - ScienceDirect
Immunoglobulin germline gene variation and its impact on human disease | Genes & Immunity
View of Impaired Memory B-Cell Response to Influenza Immunization in Patients With Common Variable Immunodeficiency (CVID) | Pathogens and Immunity
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera - ScienceDirect
